BofA analyst Allen Lutz raised the firm’s price target on Envista (NVST) to $24 from $23 and keeps a Buy rating on the shares after the company delivered “a strong 1Q print against muted expectations.” FY25 EPS should fare better than the firm anticipated, unless the end-market worsens meaningfully, as Envista has line of sight into tariff mitigation and control on below the line items, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVST:
- Envista price target lowered to $18 from $21 at UBS
- Cautious Outlook on Envista Holdings Amid Uncertain Dental Demand and Geographic Challenges
- Envista Holdings’ Earnings Call: Balanced Growth Amid Challenges
- Envista price target lowered to $21 from $23 at Baird
- Balanced Outlook on Envista Holdings: Hold Rating Amid Stable Dental Market and Macroeconomic Caution